Provided by Tiger Trade Technology Pte. Ltd.

Aurinia Pharmaceuticals

16.65
-0.6200-3.59%
Post-market: 16.650.00000.00%19:31 EDT
Volume:1.25M
Turnover:21.02M
Market Cap:2.22B
PE:7.23
High:17.32
Open:17.20
Low:16.63
Close:17.27
52wk High:19.25
52wk Low:10.34
Shares:133.05M
Float Shares:129.00M
Volume Ratio:0.91
T/O Rate:0.97%
Dividend:- -
Dividend Rate:- -
EPS(TTM):2.30
EPS(LYR):2.07
ROE:66.12%
ROA:15.49%
PB:3.60
PE(LYR):8.04

Loading ...

Aurinia Pharmaceuticals (AUPH) After The Teva Settlement Is The Stock A Bargain

Simply Wall St.
·
Yesterday

Aurinia Shares Gains After Settling Patent Lawsuit with Teva

Dow Jones
·
Aug 20

Aurinia Pharmaceuticals (AUPH) Gets a Buy from TD Cowen

TIPRANKS
·
Aug 20

Aurinia settles patent litigation with Teva

TIPRANKS
·
Aug 20

Aurinia Settles Teva Patent Suit, Bars Generic Voclosporin Launch Until Dec. 7, 2036

Reuters
·
Aug 20

Aurinia Pharmaceuticals - Teva May Launch Generic Voclosporin in U.S. no Earlier than December 7, 2036

THOMSON REUTERS
·
Aug 20

Aurinia Pharmaceuticals - Continues Patent Litigation Against Multiple Generic Companies in New Jersey

THOMSON REUTERS
·
Aug 20

Aurinia Settles Patent Litigation with Teva

THOMSON REUTERS
·
Aug 20

CannaPharmaRx Q2 FY26 Net Loss Widens to USD 1.91 Million; Revenue Rises 19.26% to USD 276,218

Reuters
·
Aug 19

Aurinia Pharmaceuticals is Maintained at Sector Perform by RBC Capital

Dow Jones
·
Aug 08

RBC Adjusts PT on Aurinia Pharmaceuticals to $16 From $15, Keeps Sector Perform Speculative Risk Rating

MT Newswires Live
·
Aug 07

Analysts’ Opinions Are Mixed on These Healthcare Stocks: VistaGen Therapeutics (VTGN), Iovance Biotherapeutics (IOVA) and Aurinia Pharmaceuticals (AUPH)

TIPRANKS
·
Aug 06

Aurinia Pharmaceuticals Q2 EPS $0.28 Beats $0.24 Estimate, Sales $83.220M Beat $79.357M Estimate

Benzinga Earnings
·
Aug 06

Aurinia Publishes Corporate Presentation Outlining Lupkynis Growth Strategy, Aritinercept Development Plans

Reuters
·
Aug 06

Aurinia Pharmaceuticals Q2 Pretax Profit USD 48.786 Million

Reuters
·
Aug 06

Aurinia Pharmaceuticals sees FY26 revenue $315M-$325M, consensus $325.82M

TIPRANKS
·
Aug 06

Aurinia Q2 Net Income Climbs 74% to $37.4 Million; Revenue Rises 19% to $83.2 Million

Reuters
·
Aug 06

Aurinia Pharmaceuticals Q2 Product Revenue USD 79.412 Million

THOMSON REUTERS
·
Aug 06

Press Release: Aurinia Pharmaceuticals Reports Financial Results for the Three and Six Months Ended June 30, 2026 and Provides Update on Recent Business Progress

Dow Jones
·
Aug 06

Aurinia Pharmaceuticals (AUPH) Stock Still Looks Cheap Despite Its 50% Gain

Simply Wall St.
·
Aug 04